C1GALT1 and hepatocellular carcinoma: Significantly higher C1GalT1 expression at protein or mRNA levels is seen in lung [23], colon [24,25], breast [26,27], gastric [28,29], head and neck [30], pancreatic [31], esophageal [32], prostate [33], ovarian [34], and hepatocellular cancers [35] (Table 1).